| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
6,297,900 | 6,235,700 | 6,213,600 | 5,951,400 | 5,665,200 |
| Cost of Revenue
|
-996,000 | -1,014,600 | -1,016,300 | -971,000 | -919,300 |
|
Gross Profit
|
5,301,900 | 5,221,100 | 5,197,300 | 4,980,400 | 4,745,900 |
| Selling, General and Administrative Expenses
|
-2,073,100 | -2,159,200 | -2,174,800 | -2,075,100 | -1,942,400 |
|
Research and Development Expenses
|
-1,291,500 | -1,323,300 | -1,286,200 | -1,228,300 | -1,087,200 |
| Depreciation, Amortization and Depletion
|
-323,600 | -337,600 | -361,600 | -378,900 | -401,900 |
|
Other Income/Expense, Operating
|
-76,900 | -6,400 | 1,200 | -7,800 | -- |
|
Operating Income/Expenses
|
-3,765,100 | -3,826,500 | -3,821,400 | -3,690,100 | -3,431,500 |
|
Total Operating Profit/Loss
|
1,536,800 | 1,394,600 | 1,375,900 | 1,290,300 | 1,314,400 |
| Total Net Finance Income/Expense
|
88,400 | 105,400 | 128,100 | 69,700 | 11,800 |
| Net Investment Income
|
-1,300 | -1,300 | -9,700 | -10,700 | -9,100 |
| Irregular Income/Expenses
|
-40,300 | -40,300 | -16,300 | -48,300 | -11,400 |
|
Non-Operating Income/Expenses, Total
|
88,400 | 63,800 | 102,100 | 10,700 | -8,700 |
|
Pretax Income
|
1,625,400 | 1,458,400 | 1,478,000 | 1,300,900 | 1,305,600 |
|
Provision for Income Tax
|
-285,900 | -270,800 | -279,900 | -250,700 | -375,400 |
|
Net Income from Continuing Operations
|
1,339,500 | 1,187,600 | 1,198,100 | 1,050,200 | 930,200 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
1,339,500 | 1,187,600 | 1,198,100 | 1,050,200 | 930,200 |
|
Non-Controlling/Minority Interests
|
100 | 8,300 | 2,100 | 700 | 1,300 |
|
Net Income after Non-Controlling/Minority Interests
|
1,339,600 | 1,196,000 | 1,200,200 | 1,050,900 | 931,500 |
|
Net Income Available to Common Stockholders
|
1,339,600 | 1,196,000 | 1,200,200 | 1,050,900 | 931,500 |
|
Dilution to Earnings
|
0 | -- | -- | -- | -- |
|
Diluted Net Income Available to Common Stockholders
|
1,339,600 | 1,196,000 | 1,200,200 | 1,050,900 | 931,500 |
|
Common Dividend per Share
|
0.27 | 0.27 | 0.26 | 0.23 | 0.21 |
| Basic EPS
|
1.01 | 0.91 | 0.91 | 0.80 | 0.71 |
| Diluted EPS
|
0.99 | 0.90 | 0.90 | 0.79 | 0.70 |
|
Basic Weighted Average Shares Outstanding
|
1,321,097.56 | 1,317,197.56 | 1,313,306.09 | 1,315,087.12 | 1,312,255.97 |
|
Diluted Weighted Average Shares Outstanding
|
1,329,350.52 | 1,328,450.52 | 1,333,387.46 | 1,336,796.85 | 1,332,663.01 |
|
Reported Normalized Diluted EPS
|
1.33 | 1.31 | 1.28 | 1.20 | 1.13 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
1,537,000 | 1,350,500 | 1,348,000 | 1,202,600 | 1,291,800 |
12/31/2022 - 8/3/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade